Mabcampath and febrile neutropenia Patient Reports February 11, 2012

Mabcampath Side Effects Report #6039680-6
Mabcampath side effect was reported by a Physician from FRANCE on Jan 09, 2009. Female patient, 62 years of age, weighting 105.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 01/03/2009.

Mabcampath Side Effects Report #6041871-5
Mabcampath side effect was reported by a Physician from FRANCE on Jan 09, 2009. Female patient, 62 years of age, weighting 105.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 01/03/2009.

Mabcampath Side Effects Report #6070449-2
Mabcampath side effect was reported by a Physician from FRANCE on Feb 05, 2009. Female patient, 62 years of age, weighting 105.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 01/03/2009.

Mabcampath Side Effects Report #6081141-2
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on Feb 05, 2009. Female patient, 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiac failure, febrile neutropenia, thrombocytopenia. Mabcampath dosage: 30 MG SUBCUTANEOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died.


Mabcampath Side Effects Report #6068436-3
Mabcampath side effect was reported by a Physician from BELGIUM on Jan 29, 2009. Male patient, 61 years of age, weighting 178.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: chronic lymphocytic leukaemia transformation, diffuse large b-cell lymphoma, febrile neutropenia, pancytopenia, pneumonia . Mabcampath dosage: unknown. Patient recovered.

Mabcampath Side Effects Report #6093696-2
Mabcampath side effect was reported by a Health Professional from FRANCE on Feb 04, 2009. Female patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: bone marrow failure, febrile neutropenia, hypotension. Mabcampath dosage: 30 MG, SUBCUTANEOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, BACTRIM, VALACYCLOVIR. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #6094333-3
Mabcampath side effect was reported by a Health Professional from FRANCE on Feb 04, 2009. Male patient, 59 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: bone marrow failure, bronchiectasis, bronchopulmonary aspergillosis, chest pain , eczema , febrile neutropenia, lymphadenopathy mediastinal, pancytopenia, rash erythematous. Mabcampath dosage: 30 MG; SUBCUTANEOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, AUGMENTIN, BACTRIM, VALACYCLOVIR, PENTACARINAT. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #5558120-4
Mabcampath side effect was reported by a Physician from UNITED STATES on Nov 22, 2007. Male patient, 68 years of age, was diagnosed with b-cell small lymphocytic lymphoma, infection prophylaxis, erosive duodenitis, diarrhoea, anaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: febrile neutropenia, hepatitis c antibody positive, jaundice . Mabcampath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, BISEPTOL, ACYCLOVIR, OMEPRAZOLE, HILAC, FERROUS SULPHATE, EPOETIN ALFA, LOPERAMIDE. Patient was hospitalized. Patient died.

Mabcampath Side Effects Report #5610983-X
Mabcampath side effect was reported by a Physician from UKRAINE on Jan 21, 2008. Male patient, 68 years of age, was diagnosed with b-cell small lymphocytic lymphoma, infection prophylaxis, erosive duodenitis, diarrhoea, anaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: febrile neutropenia, jaundice . Mabcampath dosage: UNIT DOSE: 30 MG. During the same period patient was treated with FLUDARABINE PHOSPHATE, BISEPTOL, ACYCLOVIR, OMEPRAZOLE, HILAC, SORBIFER DURULES, EPREX. Patient was hospitalized. Patient died on 12/01/2007.


Mabcampath Side Effects Report #5660610-0
Mabcampath side effect was reported by a Physician from UKRAINE on Mar 03, 2008. Male patient, 68 years of age, was diagnosed with b-cell small lymphocytic lymphoma, infection prophylaxis, erosive duodenitis, diarrhoea, anaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, febrile neutropenia, hepatitis c . Mabcampath dosage: UNIT DOSE: 30 MG. During the same period patient was treated with FLUDARABINE PHOSPHATE, BISEPTOL, ACYCLOVIR, OMEPRAZOLE, HILAC, SORBIFER DURULES, EPREX. Patient was hospitalized. Patient died on 12/01/2007.

Mabcampath Side Effects Report #5660684-7
Mabcampath side effect was reported by a Physician from UKRAINE on Mar 03, 2008. Male patient, 68 years of age, was diagnosed with b-cell small lymphocytic lymphoma, infection prophylaxis, erosive duodenitis, diarrhoea, anaemia and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardiopulmonary failure, febrile neutropenia, hepatitis c . Mabcampath dosage: UNIT DOSE: 30 MG. During the same period patient was treated with FLUDARABINE PHOSPHATE, BISEPTOL, ACYCLOVIR, OMEPRAZOLE, HILAC, SORBIFER DURULES, EPREX. Patient was hospitalized. Patient died on 12/01/2007.

Mabcampath Side Effects Report #5993328-5
Mabcampath side effect was reported by a Consumer or non-health professional from FRANCE on Dec 05, 2008. Male patient, 67 years of age, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, febrile neutropenia, pneumonia , thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 11/13/2008.

Mabcampath Side Effects Report #6017147-9
Mabcampath side effect was reported by a Physician from FRANCE on Dec 05, 2008. Male patient, 67 years of age, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, febrile neutropenia, pneumonia , thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 11/13/2008.

Mabcampath Side Effects Report #6070451-0
Mabcampath side effect was reported by a Physician from FRANCE on Feb 05, 2009. Male patient, 67 years of age, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, febrile neutropenia, pneumonia , thrombocytopenia. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, ENDOXAN. Patient was hospitalized. Patient died on 11/13/2008.